Immuno Cure opens HIV therapeutic DNA vaccine research facility at international innovation centre
May 28, 2026 | 10:19
Hong Kong Science Park-based Immuno Cure Group has inaugurated a dedicated research facility for its HIV therapeutic DNA vaccine ICVAX® at the Center of International Innovation for Technology and Science, marking a significant step in advancing the candidate toward clinical development.
Latest News
Mobile Version